Posttraumatic intrusions (repetitive and distressing memories, thoughts, or images of a traumatic event) and the link to mental imagery

Observational longitudinal examination of characteristics and frequency of posttraumatic intrusions and correlation with both visual and multi-sensory mental imagery during day-care or inpatient PTSD treatment.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN13971445

Enrollment

Registered

2023-02-15

Start date

2023-02-24

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Development of posttraumatic intrusions during day-care or inpatient PTSD treatment. Mental and Behavioural Disorders

Interventions

Inpatients or day-care patients suffering from PTSD record frequency and characteristics of their posttraumatic intrusions in a digital intrusion diary on a daily basis. At the start (T0) and the end

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Inpatient or day-care PTSD treatment at the Department of Psychosomatic Medicine and Psychotherapy of the LWL-University Hospital of the Ruhr-University Bochum. 2. Diagnosis of Posttraumatic stress disorder according to ICD-10 (F43.1). 3. Motivation and willingness to take part in the study. 4. Age between 18 and 65 years. 5. Sufficient knowledge of the German language.

Exclusion criteria

Exclusion criteria: 1. Active substance abuse (excluding nicotine). 2. Symptoms of psychosis within the last six months. 3. Acute suicidal tendencies or thoughts. 4. Non corrected vision.

Design outcomes

Primary

Measure	Time frame
Frequency and characteristics of posttraumatic intrusions during day care or inpatient PTSD treatment measured by a digital intrusion diary on a daily basis.	—

Secondary

Measure	Time frame
Timepoints are T0, T1 (start and end of treatment), T2, T3 (3 and 6 months after hospital discharge): 1. Severity of PTSD-related symptoms, assessed via PTSD Checklist for DSM-5 (PCL-5) at T0, T1, T2, T3. 2. Visual mental imagery, assessed via Vividness of Visual Imagery Questionnaire (VVIQ) at T0, T1, T2, T3. 3. Multi-sensory imagery, assessed via Plymouth Sensory Imagery Questionnaire (PSI-Q) at T0, T1, T2, T3. 4. Severity of depressive symptoms, assessed via Beck Depression Inventory II (BDI-II) at T0, T1, T2, T3.	—

Measure

Time frame

Timepoints are T0, T1 (start and end of treatment), T2, T3 (3 and 6 months after hospital discharge): 1. Severity of PTSD-related symptoms, assessed via PTSD Checklist for DSM-5 (PCL-5) at T0, T1, T2, T3. 2. Visual mental imagery, assessed via Vividness of Visual Imagery Questionnaire (VVIQ) at T0, T1, T2, T3. 3. Multi-sensory imagery, assessed via Plymouth Sensory Imagery Questionnaire (PSI-Q) at T0, T1, T2, T3. 4. Severity of depressive symptoms, assessed via Beck Depression Inventory II (BDI-II) at T0, T1, T2, T3.

—

Countries

Germany

Contacts

Public ContactHenrik Kessler

henrik.kessler@rub.de+49 661 846591

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026